Clinical Trial Economics, Policy & Industry Trends

High-Impact Diversity Policies & Incentives Strategies That Protect Trial Timelines and Margins High-Impact Diversity Policies & Incentives Strategies That Protect Trial Timelines and Margins In the rapidly evolving landscape of clinical trials, the implementation of diversity policies and incentives has emerged as a crucial strategy for biopharmaceutical companies. This article serves as a comprehensive guide…

Read More “High-Impact Diversity Policies & Incentives Strategies That Protect Trial Timelines and Margins” »

Diversity Policies & Incentives in Practice: Benchmarks, Case Studies and Playbooks Diversity Policies & Incentives in Practice: Benchmarks, Case Studies and Playbooks Introduction: The Importance of Diversity in Clinical Trials Diversity in clinical trials is not merely a regulatory mandate; it is essential for the development of effective and safe therapeutics across varied populations. The…

Read More “Diversity Policies & Incentives in Practice: Benchmarks, Case Studies and Playbooks” »

How to Model Diversity Policies & Incentives for Global Study Portfolios How to Model Diversity Policies & Incentives for Global Study Portfolios The need for diversity in clinical trials has gained unprecedented attention, prompted by recent movements within the healthcare and research communities. As regulatory agencies worldwide, including the FDA, EMA, and MHRA, emphasize inclusivity…

Read More “How to Model Diversity Policies & Incentives for Global Study Portfolios” »

Diversity in Clinical Trials: A Fundamental Overview In the contemporary landscape of clinical trials, diversity is not merely an ethical or social consideration; it is a regulatory imperative. The emergence of various health disparities across different demographics underscores the necessity for clinical research organization companies to implement diversity policies and incentives. By fostering inclusivity within…

Read More “Diversity Policies & Incentives: What Clinical Leaders Need to Know Now” »

Governance Models and Cross-Functional Ownership for Diversity Policies & Incentives Governance Models and Cross-Functional Ownership for Diversity Policies & Incentives Introduction to Diversity in Clinical Trials Diversity in clinical trials is critical for ensuring that the findings are applicable across various populations. Traditionally, clinical trials have been criticized for their lack of diversity, which often…

Read More “Governance Models and Cross-Functional Ownership for Diversity Policies & Incentives” »

Using Real-World Data to Inform Diversity Policies & Incentives Decisions In the evolving landscape of clinical trials, the integration of real-world data (RWD) has become increasingly important in informing diversity policies and ensuring equitable participation. This tutorial aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a step-by-step guide on leveraging RWD,…

Read More “Using Real-World Data to Inform Diversity Policies & Incentives Decisions” »

Regulatory and Policy Shifts Reshaping Diversity Policies & Incentives in the US, EU and UK Regulatory and Policy Shifts Reshaping Diversity Policies & Incentives in the US, EU and UK The landscape of clinical trials is undergoing substantial transformations as regulatory authorities in the US, EU, and UK respond to the ongoing need for enhanced…

Read More “Regulatory and Policy Shifts Reshaping Diversity Policies & Incentives in the US, EU and UK” »

Risk Scenarios and Sensitivity Analyses for Diversity Policies & Incentives In the evolving landscape of clinical research, the importance of diversity in clinical trial populations is increasingly recognized. Diversity policies and incentives are essential for ensuring that clinical trials are representative of the broader population. This tutorial provides a detailed framework for conducting risk scenarios…

Read More “Risk Scenarios and Sensitivity Analyses for Diversity Policies & Incentives” »

Digital Tools and Analytics to Forecast and Monitor Diversity Policies & Incentives Digital Tools and Analytics to Forecast and Monitor Diversity Policies & Incentives As the landscape of clinical trials becomes increasingly intricate, ensuring diversity in patient recruitment has become a critical focus for organizations engaged in clinical research. This tutorial will provide a comprehensive…

Read More “Digital Tools and Analytics to Forecast and Monitor Diversity Policies & Incentives” »

<!– Future Trends: AI, RWE and New Business Models in Diversity Policies & Incentives –> Future Trends: AI, RWE and New Business Models in Diversity Policies & Incentives The evolution of clinical trials is increasingly shaped by advancements in technology and regulatory frameworks focused on diversity. This tutorial offers a comprehensive guide for clinical operations,…

Read More “Future Trends: AI, RWE and New Business Models in Diversity Policies & Incentives” »